PHARMARESEARCH BIO Co., Ltd. Logo

PHARMARESEARCH BIO Co., Ltd.

A global biopharma firm creating regenerative medicine, pharmaceuticals, devices, and cosmetics.

217950 | KO

Overview

Corporate Details

ISIN(s):
KR7217950005
LEI:
Country:
South Korea
Address:
강원도 강릉시 사임당로 641-3 -, 강릉시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PHARMARESEARCH BIO Co., Ltd. is a global biopharmaceutical company dedicated to the research, development, manufacturing, and marketing of innovative biological products. A key part of the PharmaResearch group, which specializes in regenerative medicine, the company focuses on creating advanced treatments to improve human health and quality of life. Its R&D pipeline explores novel therapies and biologicals, including toxin-based technologies, contributing to a diverse portfolio that spans pharmaceuticals, medical devices, and cosmetics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-20 00:00
Share Issue/Capital Change
전환청구권행사 (제3회차)
Korean 11.2 KB
2025-04-30 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.6 KB
2025-04-23 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.0 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 9.4 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.0 MB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 10.4 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 94.3 KB
2024-12-30 00:00
Regulatory News Service
[기재정정]신규시설투자등
Korean 10.7 KB
2024-12-16 00:00
Notice of Dividend Amount
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 5.6 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-11-26 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차)
Korean 8.9 KB
2024-10-29 00:00
Report Publication Announcement
기업설명회(IR)개최결과
Korean 6.5 KB
2024-10-22 00:00
Legal Proceedings Report
불성실공시법인미지정
Korean 4.6 KB
2024-10-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB

Automate Your Workflow. Get a real-time feed of all PHARMARESEARCH BIO Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PHARMARESEARCH BIO Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PHARMARESEARCH BIO Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland
IDIA
IGC Pharma, Inc. Logo
Clinical-stage pharma creating Alzheimer's therapies & AI-powered diagnostics.
United States of America
IGC
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea
007570
I-Mab Logo
A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.
United States of America
IMAB
ImageneBio, Inc. Logo
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
United States of America
IMA
IM Cannabis Corp. Logo
International producer of medical-grade cannabis for patients and providers in Israel and Germany.
United States of America
IMCC
Immatics N.V. Logo
Develops T-cell redirecting immunotherapies (ACT & TCR Bispecifics) for solid tumor cancers.
United States of America
IMTX
Immix Biopharma, Inc. Logo
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX

Talk to a Data Expert

Have a question? We'll get back to you promptly.